Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable […]
In fall 2016, EUROIMMUN Canada celebrated the opening of its new facilities in Mississauga, Ontario.
On 22 September, EUROIMMUN celebrated the roofing ceremony of the new “House of Engineers” in Dassow, only 14 months after the official laying of the cornerstone. About 60 guests were invited, including the administrative head of the district, Mrs. Weiss, Minister of Economics, Construction and Tourism in Mecklenburg-West Pomerania, Mr. Glawe, and the Deputy Mayor
In summer 2016, Análisis Y Genética S. L. (Madrid, Spain) and ANAGENE, LDA. (Amadora, Portugal) were incorporated into the EUROIMMUN Group as new subsidiaries after 16 years of successful distribution partnership. All 16 experienced employees and the managing director for many years of Análisis Y Genética S. L., Pedro Cayuela, remain with the Spanish subsidiary,
2015 was yet again a very satisfying year for EUROIMMUN, as announced at the Annual Meeting of Shareholders on 8 July 2016. This year, around 750 shareholders assisted the meeting, which is a new record. With an increase of 17.5%, the Group turnover exceeded the threshold of 200 million euros for the first time (amounting
